Shengling Huang

26PUBLICATIONS
66CO-AUTHORS
Molecular targetsMedical devicesMining, energy and natural resources lawCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 21, 2026
Decoding neoantigen-encoding tumor-specific transcripts unveils a shared target reservoir for immunotherapy in hepatocellular carcinoma.

|May 08, 2026
Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases.

|Feb 26, 2026
An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice.

Hongwu Yu, Yu Yang, Peng Lin

|Oct 16, 2025
exoRBase 3.0: an updated resource for extracellular RNAs from human biofluids.

Wenqian Yu, Jia Hu, Peng Lin

|Mar 11, 2025
p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy.

Mingming Cao, Yu Gan, Yingdan Huang

|Sep 27, 2024
NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations.

Wenqian Yu, Hongwu Yu, Jingjing Zhao

Pageof 5

Frequent Collaborators

7 joint publications

Xianghuo He

2 joint publications

Linhui Liang

2 joint publications

Yan Li

2 joint publications

Huijuan Yang